ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Harbour BioMed Presented Pre-Clinical Data on A Fully Human Anti-CD73 Antibody at AACR Virtual Annual Meeting
July 16, 2020Harbour BioMed (HBM), a global clinical stage biopharmaceutical company, today announced that the Company presented preclinical data from a fully human CD73 antibody (HBM1007) in an e-poster at the American Association for Cancer Research (AACR) Virtual A
Pharma Sources Insight January 2025
